Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Global publication plans

- PMLiVE

FDA gives Alexion’s metabolic drug breakthrough status

Reduces requirements for registration, potentially speeding up approval

- PMLiVE

Amgen boosts Japan prospects with Astellas partnership

Companies establish joint venture and plan to co-develop new medicines

- PMLiVE

Gilead launches combination HIV pill in UK and Germany

Stribild is approved in EU as once-daily single tablet

- PMLiVE

New report points to demise of stand-alone digital agencies

85 per cent of marketing graduates believe social media and digital will integrate into full-service agencies

- PMLiVE

Sanofi hires David Loew from Roche

Will head commercial operations in Europe

- PMLiVE

Organs on demand: the future of transplants

Researchers in the US have transplanted lab-grown kidneys into animals that are functional and produce urine, though not as efficiently as the real thing

- PMLiVE

Boehringer/ Lilly launch online diabetes management game

Pharma companies aim to raise awareness of type 2 diabetes complications

- PMLiVE

AstraZeneca offers $443m to buy Omthera

Adds to list of deals to boost flagging pipeline

- PMLiVE

Bayer wins EU approval for Xarelto in ACS

Comes despite US FDA decision not to recommend extra indication for anticoagulant

- PMLiVE

Valeant buys Bausch + Lomb for $8.7bn

Biggest deal yet for acquisition-hungry Canadian pharma company

- PMLiVE

Novo Nordisk on track to file liraglutide in obesity

Expects regulatory filings in the US and EU by the beginning of 2014

- PMLiVE

Big ideas are not born survivors

You’ve nailed the brief and have a killer idea. Job done. Err, not quite. It can still stall if it’s not sold to the client with conviction…

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links